Dibenzazepine (YO-01027)

Catalog No.S2711

Dibenzazepine (YO-01027) Chemical Structure

Molecular Weight(MW): 463.48

Dibenzazepine (YO-01027) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM in cell-free assays for APPL and Notch cleavage, respectively.

Size Price Stock Quantity  
In DMSO USD 294 In stock
USD 120 In stock
USD 210 In stock
USD 670 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 17 Publications

4 Customer Reviews

  • Tumor spheres formation assay. Images were taken at 48 h after treating the cells with various formulations of YO (scale bar 100 um).

    Journal of Pharmaceutical Investigation 2014 10.1007/s40005-014-0151-2. Dibenzazepine (YO-01027) purchased from Selleck.

  • NSG mice were engrafted with human DND41 cells in 3 independent experiments. After DBZ treatment, marrow leukemia burden was determined by the expression of human CD45 (hCD45). Host LSK (hCD45−) (A), OB (B) and MSC frequencies (C) were determined by FACS in control (receiving culture medium) or in xenografted mice treated with vehicle or DBZ (n=8–9.group).

    Cancer Res, 2016, 76(6):1641-52. Dibenzazepine (YO-01027) purchased from Selleck.

  • Inhibition of Notch signaling by dibenzazepine (DBZ) leads to decreased cell proliferation and secretory cell hyperplasia. The intestine isolated from stage‐56/57 tadpoles was cultured with 20 nM T3 for 5 (A-F) or 7 (G-J) days in the presence of DMSO (A, C, E, G, I) or 10 μM DBZ (B, D, F, H, J) after precultivation of the isolated intestinal fragments with DMSO or 10 μM DBZ for 3 days (see Fig. ​Fig.4A).4A). Cryosections of the intestinal fragments were hybridized with antisense Hairy1 (A, B) or Hairy2b (C, D). Paraffin sections were incubated with anti‐PCNA (E, F) or anti-IFABP (G, H) antibodies or subjected to Periodic acid‐Schiff (PAS) staining followed by counter-staining with hematoxylin (I, J). As a control, paraffin sections of the intestine from wild type froglets at stage 66 were also stained with PAS to identify goblet cells (K, arrowheads). Note that after 5 days, TH‐induced up‐regulation of Hairy genes (A, C, arrowheads) was impaired by DBZ treatment in vitro (B, D). PCNA‐positive epithelial cells also decreased by DBZ treatment (E, F, arrowheads). After 7 days, IFABP was detected in most of the newly formed adult epithelial cells of the control intestine (G, arrowheads), but not the DBZ-treated intestine (H). A small number of goblet cell was detected in the control intestine (I, arrowhead), whereas PAS-positive secretory cells increased by DBZ treatment (J, arrowheads). The dashed-lines indicate the boundary of the epithelium and the connective tissue. Scale bars = 20 μm. Abbreviations: CT, connective tissue, DBZ, dibenzazepine, Ep, epithelium, PAS, Periodic acid‐Schiff.

    Stem Cells, 2017, 35(4):1028-1039. Dibenzazepine (YO-01027) purchased from Selleck.

  • Overexpression of PrP enhances Notch1 signaling and cancer cell growth and invasion. Capan-1 cells were transfected with control or PrP-expressing plasmid. A: Expression of PrP, Notch1, and Hes1 was assessed by immunoblotting. N1 and Hes1 expression was also assessed after DBZ treatment (20 μmol/L for 48 hours) (right two columns). B and C: PrP-OE increases cell growth (B) and migration (C), although DBZ treatment decelerates Capan-1 proliferation and migration. D: Control or PrP-OE Capan-1 cells were injected ipsilaterally on the back of nude mice. Paired animals received either PBS (control or PrP-OE) or DBZ (control + DBZ or PrP-OE + DBZ) for 3 consecutive days every 7 days. Tumors were dissected at the end of 6 weeks. Tumor volumes were measured weekly and at the end of experiments. Data are expressed as means ± SD. t-test was performed (B–D). n = 3 independent experiments (A); n = 6 mice (B and C); n = 8 biological replicates (B and C); n = 5 mice in each group (D). ∗P < 0.05, ∗∗P < 0.01. Ctrl, control; DBZ, dibenzazepine; N1, Notch1; OE, overexpression; PBS, phosphate-buffered saline; PrP, prion protein.

    Am J Pathol, 2016, 186(11):2945-2956. Dibenzazepine (YO-01027) purchased from Selleck.

Purity & Quality Control

Choose Selective Gamma-secretase Inhibitors

Biological Activity

Description Dibenzazepine (YO-01027) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM in cell-free assays for APPL and Notch cleavage, respectively.
γ secretase(APPL) [1]
(Cell-free assay)
γ secretase(Notch) [1]
(Cell-free assay)
2.6 nM 2.9 nM
In vitro

YO-01027 interacts directly with theγ-secretase complex and targets the N-terminal Presenilin fragment. Increasing concentrations of YO-01027 administered to APPL- or Notch-expressing cells leads to the progressive accumulation of APPL CTF fragments and a decrease in NICD production in a strictly dose-dependent manner. [1] 10 μM of YO-01027 reduces breast cancer stem cells (BCSC) number and activity. [2] A recent research indicates YO-01027 impairs mucin protein MUC16 biosynthesis in a concentration-dependent manner in undifferentiated cells at both preconfluent and confluent stages through Notch inhibition, but not in postmitotic stratified cells. [3]

In vivo YO-01027, which is delivered 1 mg/mL by i.p. injection on the day of cell injection and every subsequent 3 days, YO-01027 significantly, decreases MCF7 but not MDA-MB-231 tumors and increases latency compared with control mice (18-28 days). YO-01027-treated MCF7 tumors that did form had significantly reduced tumor volumes. [2] Treatment of YO-01027 into C57BL/6 mice inhibits epithelial cell proliferation and induces goblet cell differentiation in intestinal adenomas in a dose-dependent manner. [4]


Kinase Assay:


- Collapse

Pharmacological Inhibition of γ-secretase Activity:

For YO-01027, pilot experiments are performed with different drug concentrations ranging from 0.1 nM to 250 nM to determine the effective linear range and maximal inhibition dose for YO-01027. YO-01027 is added at the required concentrations to the S2 cell medium upon induction of Notch or APPL expression, 6 hours before protein harvesting. For each sample, YO-01027 is also included at the corresponding concentration in the lysis buffer for protein extraction and immunoblot analysis.
Cell Research:


- Collapse
  • Cell lines: BCSC
  • Concentrations: 10 μM
  • Incubation Time: 3 days
  • Method:

    Cells are resuspended at ≤1 × 106 in 100 μL sorting buffer (PBS containing 0.5% bovine serum albumin, 2 mM EDTA) and incubated with preconjugated primary antibodies BEREP4-FITC (1:10), CD44-APC (1:20), and CD24-PE (1:10) for 10 minutes at 4 °C. The cells are washed in PBS and centrifuged at 800 × g for 2 minutes. For analysis, cells are resuspended in 500 μL of sorting buffer and fluorescence is measured using FACSCalibur and analyzed using WinMIDI 2.8. For sorting, cells are resuspended in 1× HBSS after incubation with the primary antibodies. Cells are sorted, with HBSS as sheath fluid, at 16 p.s.i. using FACSAria. The CD24low cell population gated by FACS is the lowest quintile of CD24-positive cells plus all the CD24-negative cells.

    (Only for Reference)
Animal Research:


- Collapse
  • Animal Models: C57BL/6 mice
  • Formulation: YO-01027 is suspended finely in 0.5% (w/v) hydroxypropylmethylcellulose (Methocel E4M) and 0.1% (w/v) Tween 80 in water.
  • Dosages: 0, 3, 10, 30 μmol/kg
  • Administration: Injected daily intraperitoneally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 92 mg/mL (198.49 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
0.5% hydroxyethyl cellulose
For best results, use promptly after mixing.
6 mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 463.48


CAS No. 209984-56-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    How to dissolve the compund for in vivo applications?

  • Answer:

    For S2711, we suggest to use 0.5% hydroxyethyl cellulose in vivo study.

Gamma-secretase Signaling Pathway Map

Gamma-secretase Inhibitors with Unique Features

Related Gamma-secretase Products

Tags: buy Dibenzazepine (YO-01027) | Dibenzazepine (YO-01027) supplier | purchase Dibenzazepine (YO-01027) | Dibenzazepine (YO-01027) cost | Dibenzazepine (YO-01027) manufacturer | order Dibenzazepine (YO-01027) | Dibenzazepine (YO-01027) distributor
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID